Interferon-γ control of EBV-transformed B cells: A role for CD8+ T cells that poorly kill EBV-infected cells

Viral Immunology

Volumn 15, Issue 1, 2002, Pages 213-225

  Shi, Yan ^a   Lutz, Charles T ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERFERON ANTIBODY; MONOCLONAL ANTIBODY;

ARTICLE; B LYMPHOBLAST; B LYMPHOCYTE; CELL GROWTH; CELL KILLING; CELL STIMULATION; CELL TRANSFORMATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IN VIVO STUDY; INFECTION CONTROL; LYMPHOCYTE CLONE; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE; VIRUS INFECTION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0036206297     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/088282402317340350     Document Type: Article

References (54)

1. Early events in Epstein-Barr virus infection of human B lymphocytes
2. Clinical and immunological considerations in Epstein-Barr virus-associated diseases
3. Interferon γ (IFN-γ) deficiency in generalized Epstein-Barr virus infection with interstitial lymphoid and granulomatous pneumonia, focal cerebral lesions, and genital ulcers: Remission following IFN-γ substitution therapy
4. Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients
5. Signaling through CD19, Fc receptors or transforming growth factor-β: Each inhibits the activation of resting human B cells differently
6. Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses
7. The importance of exogenous antigen in priming the human CD8+ T cell response: Lessons from the EBV nuclear antigen EBNA1
8. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing
9. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus
10. + T cells during the primary immune response to Epstein-Barr virus in vivo
11. Gamma interferon (IFN-γ) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-γ ligand null-mutant mice
12. Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells
13. + T-cell mechanisms in the control of respiratory virus infections
14. Pathological changes in the spleens of gamma interferon receptor-deficient mice infected with murine gammaherpesvirus: A role for CD8 T cells
15. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes
16. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells
17. Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients
18. Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation
19. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape
20. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV) nuclear antigens fail to lyse the EBV-transformed B lymphoblastoid cell lines against which they were raised
21. EBV-specific CD8+ T cell memory: Relationships between epitope specificity, cell phenotype, and immediate effector function
22. Epstein-Barr virus and its replication
23. + memory cells
24. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
25. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1
26. Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
27. Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-γ
28. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans
29. Epstein-Barr virus. Biology, pathogenesis, and medical aspects
30. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivated in vitro
31. Functional diversity of the CD8(+) T-cell response to Epstein-Barr virus (EBV): Implications for the pathogenesis of EBV-associated lymphoproliferative disorders
32. Adoptive immunotherapy for Epstein Barr virus-associated lymphoproliferative disorders complicating marrow allografts
33. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes
34. Cytokines and immunity to viral infections
35. Cytotoxic T lymphocyte responses to Epstein-Barr virus
36. Long-term T-cell-mediated immunity to Epstein-Barr virus in man. II. Components necessary for regression in virus-infected leukocyte cultures
37. Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines
38. Gamma interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68
39. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes
40. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: Immunodominance is elicited by a peptide epitope that is presented at low levels in vitro
41. Analysis of cellular immune response to EBV by using cloned T cell lines
42. Alloreactive cytotoxic T-lymphocyte-defined HLA-B7 subtypes differ in peptide antigen presentation
43. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response
44. Epstein-Barr virus infections: Biology, pathogenesis and management
45. Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cells
46. Post-transplant lymphoproliferative disorders: Implications for acquired immunodeficiency syndrome-associated malignancies
47. Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21)-Expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/1pr mice
48. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
49. The suppression of the Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell
50. The transformation of adult but not newborn human lymphocytes by Epstein Barr virus and phytohemagglutinin is inhibited by interferon: The early suppression by T cells of Epstein Barr infection is mediated by interferon
51. A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells
52. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
53. Immunological control of murine gammaherpesvirus infection is independent of perforin
54. Fine specificity of human HLA-B7-specific cytotoxic T-lymphocyte clones. I. Identification of HLA-B7 subtypes and histotopes of the HLA-B7 cross-reacting group